Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as recurrent acute disseminated encephalomyelitis: Case report of the youngest Mexican patient in the literature
Christian García-Estrada, Enrique Gómez-Figueroa, Juan Pablo Morelos-Cisneros, Alondra Deras-Martinez
{"title":"Myelin oligodendrocyte glycoprotein antibody-associated disease presenting as recurrent acute disseminated encephalomyelitis: Case report of the youngest Mexican patient in the literature","authors":"Christian García-Estrada, Enrique Gómez-Figueroa, Juan Pablo Morelos-Cisneros, Alondra Deras-Martinez","doi":"10.1111/cen3.12729","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Myelin oligodendrocyte glycoprotein antibody-associated disease myelin oligodendrocyte glycoprotein antibody-associated disease is an emerging demyelinating condition distinct from neuromyelitis optica spectrum disorder and multiple sclerosis affecting both children and adults with a spectrum of clinical manifestations ranging from optic neuritis, myelitis and acute disseminated encephalomyelitis.</p>\n </section>\n \n <section>\n \n <h3> Case report</h3>\n \n <p>We describe the case of a 2 year-old girl diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease presenting as recurrent acute disseminated encephalomyelitis who showed suppression of disease activity after treatment with rituximab. This case represents the youngest Mexican patient with myelin oligodendrocyte glycoprotein antibody-associated disease reported to date.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Information regarding the clinical presentation and evolution among different population could help to a better understanding of the presentation of this entity.</p>\n </section>\n </div>","PeriodicalId":10193,"journal":{"name":"Clinical and Experimental Neuroimmunology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Neuroimmunology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cen3.12729","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Myelin oligodendrocyte glycoprotein antibody-associated disease myelin oligodendrocyte glycoprotein antibody-associated disease is an emerging demyelinating condition distinct from neuromyelitis optica spectrum disorder and multiple sclerosis affecting both children and adults with a spectrum of clinical manifestations ranging from optic neuritis, myelitis and acute disseminated encephalomyelitis.
Case report
We describe the case of a 2 year-old girl diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease presenting as recurrent acute disseminated encephalomyelitis who showed suppression of disease activity after treatment with rituximab. This case represents the youngest Mexican patient with myelin oligodendrocyte glycoprotein antibody-associated disease reported to date.
Conclusions
Information regarding the clinical presentation and evolution among different population could help to a better understanding of the presentation of this entity.